These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 17000904

  • 21. Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis?
    Preiss DJ, Sattar N.
    Int J Clin Pract; 2007 Apr; 61(4):697-701. PubMed ID: 17394445
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
    Zhang LN, Vincelette J, Cheng Y, Mehra U, Chen D, Anandan SK, Gless R, Webb HK, Wang YX.
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
    [Abstract] [Full Text] [Related]

  • 23. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.
    Waldeck J, Häger F, Höltke C, Lanckohr C, von Wallbrunn A, Torsello G, Heindel W, Theilmeier G, Schäfers M, Bremer C.
    J Nucl Med; 2008 Nov; 49(11):1845-51. PubMed ID: 18927332
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells.
    Lin CP, Chen YH, Chen JW, Leu HB, Liu TZ, Liu PL, Huang SL.
    J Biomed Sci; 2008 Mar; 15(2):183-96. PubMed ID: 17906965
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
    Olofsson PS, Söderström LA, Wågsäter D, Sheikine Y, Ocaya P, Lang F, Rabu C, Chen L, Rudling M, Aukrust P, Hedin U, Paulsson-Berne G, Sirsjö A, Hansson GK.
    Circulation; 2008 Mar 11; 117(10):1292-301. PubMed ID: 18285570
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation.
    Zernecke A, Bidzhekov K, Ozüyaman B, Fraemohs L, Liehn EA, Lüscher-Firzlaff JM, Lüscher B, Schrader J, Weber C.
    Circulation; 2006 May 02; 113(17):2120-7. PubMed ID: 16636171
    [Abstract] [Full Text] [Related]

  • 32. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine.
    Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, Kim WK.
    Mol Imaging; 2009 May 02; 8(5):291-301. PubMed ID: 19796606
    [Abstract] [Full Text] [Related]

  • 33. Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion.
    Rohlena J, Volger OL, van Buul JD, Hekking LH, van Gils JM, Bonta PI, Fontijn RD, Post JA, Hordijk PL, Horrevoets AJ.
    Cardiovasc Res; 2009 Jan 01; 81(1):187-96. PubMed ID: 18805782
    [Abstract] [Full Text] [Related]

  • 34. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P, Ortiz-Muñoz G, López-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuán G, Lázaro A, López-Parra V, Ortega L, Egido J, Gómez-Guerrero C.
    Circ Res; 2006 Nov 24; 99(11):1188-96. PubMed ID: 17053192
    [Abstract] [Full Text] [Related]

  • 35. [Effect of PMTG on atherosclerotic lesion formation and expression of ICAM-1 and VCAM-1 in ApoE-deficient mice].
    Fang W, Zhang HX, Wang LY, Qin YW, Wu Y, Wang W, Liu B.
    Zhongguo Zhong Yao Za Zhi; 2007 Jul 24; 32(13):1320-3. PubMed ID: 17879736
    [Abstract] [Full Text] [Related]

  • 36. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.
    Jagavelu K, Tietge UJ, Gaestel M, Drexler H, Schieffer B, Bavendiek U.
    Circ Res; 2007 Nov 26; 101(11):1104-12. PubMed ID: 17885219
    [Abstract] [Full Text] [Related]

  • 37. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
    Secchiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, Rimondi E, Fabris B, Giacca M, Zauli G.
    Circulation; 2006 Oct 03; 114(14):1522-30. PubMed ID: 17000905
    [Abstract] [Full Text] [Related]

  • 38. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C, Gomez M, Calvo E, López JA, Zaragoza C.
    Arterioscler Thromb Vasc Biol; 2009 Jan 03; 29(1):27-32. PubMed ID: 18988893
    [Abstract] [Full Text] [Related]

  • 39. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.
    Circulation; 2007 May 08; 115(18):2442-50. PubMed ID: 17438151
    [Abstract] [Full Text] [Related]

  • 40. Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-/- mice: a pilot study.
    Alsaid H, De Souza G, Bourdillon MC, Chaubet F, Sulaiman A, Desbleds-Mansard C, Chaabane L, Zahir C, Lancelot E, Rousseaux O, Corot C, Douek P, Briguet A, Letourneur D, Canet-Soulas E.
    Invest Radiol; 2009 Mar 08; 44(3):151-8. PubMed ID: 19169144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.